Histone cluster 1 H2BO Inhibitors represent a specialized category of chemical compounds designed to selectively impede the activity of histone cluster 1, with a specific emphasis on the H2BO subtype. Histones, crucial in organizing DNA within the nucleus, form nucleosomes that serve as the structural foundation for chromatin. The H2BO designation refers to a variant of histone H2B, one of the core histones essential for nucleosome assembly. The H2B family of histones plays a central role in the regulation of gene expression and the modulation of chromatin architecture. Inhibitors developed for Histone cluster 1 H2BO are meticulously crafted to interact with specific regions of this histone variant, potentially influencing its binding to DNA and other proteins, thereby modulating chromatin dynamics.
The development of Histone cluster 1 H2BO Inhibitors requires an in-depth understanding of the structural characteristics of histone H2BO and its specific role within chromatin organization. These inhibitors are engineered for specificity, aiming to selectively bind to key regions of Histone cluster 1 H2BO and disrupt its normal functions. By employing these inhibitors in experimental contexts, researchers can explore the consequences of inhibiting this particular histone variant, providing valuable insights into chromatin remodeling and the intricate regulation of gene expression. The study of histones, including variants like H2BO, significantly contributes to advancing our understanding of epigenetic mechanisms, offering crucial insights into the dynamic processes governing gene regulation and the complex orchestration of cellular functions at the chromatin level.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
Panobinostat is a histone deacetylase inhibitor, impacting chromatin structure and potentially influencing the acetylation status of histones, including H2BO. | ||||||
JIB 04 | 199596-05-9 | sc-397040 | 20 mg | $177.00 | ||
JIB-04 inhibits Jumonji histone demethylases, potentially impacting histone demethylation and the transcriptional regulation of genes, including H2BO. | ||||||
ACY-1215 | 1316214-52-4 | sc-507455 | 25 mg | $110.00 | ||
Rocilinostat is a histone deacetylase inhibitor, impacting chromatin structure and potentially affecting the acetylation status of histones, including H2BO. | ||||||
UNC0638 | 1255580-76-7 | sc-397012 | 10 mg | $315.00 | ||
UNC0638 inhibits G9a, a histone methyltransferase, potentially influencing the methylation status of histones and the expression of genes, including H2BO. | ||||||
GSK-J4 | 1373423-53-0 | sc-507551 | 100 mg | $1275.00 | ||
GSK-J4 inhibits lysine demethylase, potentially influencing histone demethylation and the transcriptional regulation of genes, including H2BO. | ||||||
EPZ6438 | 1403254-99-8 | sc-507456 | 1 mg | $66.00 | ||
EPZ-6438 targets EZH2, a histone methyltransferase, potentially impacting the methylation of histones and the expression of genes like H2BO. | ||||||
(S)-2-(4-(4-Chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)-N-(4-hydroxyphenyl)acetamide | 202590-98-5 | sc-501130 | 2.5 mg | $330.00 | ||
OTX015 is a bromodomain and extraterminal (BET) protein inhibitor, disrupting interactions between BET proteins and acetylated histones, potentially influencing gene expression. | ||||||
GSK126 | 1346574-57-9 | sc-490133 sc-490133A sc-490133B | 1 mg 5 mg 10 mg | $92.00 $243.00 $306.00 | ||
GSK343 inhibits EZH2, potentially influencing histone methylation patterns and the transcriptional regulation of genes, including Histone cluster 1 H2BO. | ||||||
C646 | 328968-36-1 | sc-364452 sc-364452A | 10 mg 50 mg | $265.00 $944.00 | 5 | |
C646 is a selective inhibitor of histone acetyltransferase, modulating the acetylation of histones and influencing the expression of associated genes, including H2BO. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Decitabine is a DNA methyltransferase inhibitor, potentially influencing DNA methylation patterns and the expression of genes, including H2BO. | ||||||